Skip to content

Research and application of key technologies in the prevention and treatment of respiratory allergic diseases with the application of acupoint sticking therapy in summer(allergic rhinitis)

Research and application of key technologies in the prevention and treatment of respiratory allergic diseases with the application of acupoint sticking therapy in summer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005033
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of ''allergic rhinitis''in Western medicine, TCM diagnosis and TCM syndrome type; 2. Aged 15-65 years; 3. Those who have not received any Chinese and Western medicines within 3 months should have a TNSS score >= 4 points before enrollment; 4. Those who sign the informed consent form and are willing to follow the research protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with other nasal diseases, such as chronic rhinitis, sinusitis, nasal polyps, deviated nasal septum, etc. 2. Combined with legal infectious diseases, such as tuberculosis. 3. Pregnant and lactating patients. 4. Those with scar constitution or history of tape allergy. 5. Those with unhealed exposed wounds on the acupoint application site. 6. Combining with other major medical diseases (such as heart failure, moderate to severe hypertension, diabetes and other blood system diseases) or those who cannot cooperate with mental diseases. 7. Other diseases that are not suitable for acupoint application.

Design outcomes

Primary

MeasureTime frame
Total nasal symptom score;

Secondary

MeasureTime frame
Total serum IgE;Questionnaire of quality of life in patients with nasal conjunctivitis;Total nasal symptom score of simultaneous phenomenon;

Countries

China

Contacts

Public ContactXuan Lihua

The First Affiliated Hospital of Zhejiang Chinese Medical University

xlh1083@163.com+86 13588420630

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026